Conexeu Sciences is updating a prospectus covering 9,481,123 common shares with information from its Quarterly Report dated September 14, 2026. Investors using the registration materials must read the supplement alongside the underlying prospectus and attached quarterly report, which together provide the current information tied to the registered shares.

Key Highlights

  • The underlying prospectus is dated May 11, 2026.
  • Registration statement number 333-291845 remains associated with the prospectus materials.
  • Miles Harrison signed as chief executive officer, while Stephen D. Inouye signed as chief financial officer.

Conexeu Sciences Inc. (NASDAQ: CNXU) is updating a prospectus covering 9,481,123 shares of common stock with information from its quarterly report filed September 14, 2026. The supplement attaches that report to the prospectus materials.

9,481,123 Common Shares Covered

The prospectus forms part of Conexeu Sciences’ registration statement numbered 333-291845. Its underlying prospectus carries a May 11, 2026 date. The common-stock total covered by the prospectus is 9,481,123 shares. The quarterly report supplies the information used to update the prospectus.

Prospectus Materials Must Be Read Together

The supplement is incomplete when separated from the underlying prospectus. The attached quarterly report accompanies the updated materials. Miles Harrison signed the report as chief executive officer and principal executive officer, while Stephen D. Inouye signed as chief financial officer, principal financial officer and principal accounting officer, secretary and treasurer.